Moreover, it is worth noting that the experimental conditions using isolated BCR activation in these previous studies led to CLL lymphocyte apoptosis instead of proliferation [11], which therefore missed the malignant proliferative output of BCR engagement observed in patients. The gene discussed is BCR; the disease is B-cell chronic lymphocytic leukemia.